The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
High dose Interleukin2 (HD IL2) in metastatic renal cell carcinoma (mRCC) after prior therapy: A single centre experience.
 
Shien Chow
No Relationships to Disclose
 
Rebecca Leach
No Relationships to Disclose
 
Andrea Spencer-Shaw
No Relationships to Disclose
 
Fadhel Shaheen
No Relationships to Disclose
 
Fiona C. Thistlethwaite
No Relationships to Disclose
 
Robert E. Hawkins
Employment - Cellular Therapeutics
Leadership - Cellular Therapeutics
Stock and Other Ownership Interests - Cellular Therapeutics
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Ipsen; Novartis; pfizer
Patents, Royalties, Other Intellectual Property - Medical Research Council - Phage Antibody Patents